Preclinical evaluation of 99mTc(CO)3-aspartic-N-monoacetic acid, a renal radiotracer with pharmacokinetic properties comparable to 131I-o-iodohippurate.

MLA

Lipowska, Malgorzata, et al. “Preclinical Evaluation of 99mTc(CO)3-Aspartic-N-Monoacetic Acid, a Renal Radiotracer with Pharmacokinetic Properties Comparable to 131I-o-Iodohippurate.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 53, no. 8, Aug. 2012, pp. 1277–83. EBSCOhost, https://doi.org/10.2967/jnumed.111.102236.

APA

Lipowska, M., Klenc, J., Marzilli, L. G., & Taylor, A. T. (2012). Preclinical evaluation of 99mTc(CO)3-aspartic-N-monoacetic acid, a renal radiotracer with pharmacokinetic properties comparable to 131I-o-iodohippurate. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 53(8), 1277–1283. https://doi.org/10.2967/jnumed.111.102236

Chicago

Lipowska, Malgorzata, Jeffrey Klenc, Luigi G Marzilli, and Andrew T Taylor. 2012. “Preclinical Evaluation of 99mTc(CO)3-Aspartic-N-Monoacetic Acid, a Renal Radiotracer with Pharmacokinetic Properties Comparable to 131I-o-Iodohippurate.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 53 (8): 1277–83. doi:10.2967/jnumed.111.102236.